STTK Q3 2024 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$291M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+336.9% YoY

Gross Profit

$2M68.2% margin

Operating Income

-$18M-597.9% margin

Net Income

-$17M-556.4% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+86.3%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$112M

Total Liabilities

$15M

Stockholders' Equity

$97M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$686,000	+336.9%
Gross Profit	$2M	-$24M	+108.7%
Operating Income	-$18M	-$29M	+37.3%
Net Income	-$17M	-$28M	+39.5%

Revenue Segments

License

$3M100%